View in EDS

RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.

Saved in:
Bibliographic Details
Title: RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
Authors: Hazar-Rethinam M; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia., de Long LM; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia., Gannon OM; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia., Boros S; Department of Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Vargas AC; Department of Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Dzienis M; Department of Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Mukhopadhyay P; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia., Saenz-Ponce N; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia., Dantzic DD; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia., Simpson F; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia., Saunders NA; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia. nsaunders@uq.edu.au.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2015 Aug; Vol. 14 (8), pp. 1939-50. Date of Electronic Publication: 2015 May 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26018753
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hazar-Rethinam+M%22">Hazar-Rethinam M</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22de+Long+LM%22">de Long LM</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Gannon+OM%22">Gannon OM</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Boros+S%22">Boros S</searchLink>; Department of Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Vargas+AC%22">Vargas AC</searchLink>; Department of Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Dzienis+M%22">Dzienis M</searchLink>; Department of Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Mukhopadhyay+P%22">Mukhopadhyay P</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Saenz-Ponce+N%22">Saenz-Ponce N</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Dantzic+DD%22">Dantzic DD</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Simpson+F%22">Simpson F</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Saunders+NA%22">Saunders NA</searchLink>; Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia. nsaunders@uq.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2015 Aug; Vol. 14 (8), pp. 1939-50. <i>Date of Electronic Publication: </i>2015 May 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26018753
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-15-0076
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1939
    Titles:
      – TitleFull: RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hazar-Rethinam M
      – PersonEntity:
          Name:
            NameFull: de Long LM
      – PersonEntity:
          Name:
            NameFull: Gannon OM
      – PersonEntity:
          Name:
            NameFull: Boros S
      – PersonEntity:
          Name:
            NameFull: Vargas AC
      – PersonEntity:
          Name:
            NameFull: Dzienis M
      – PersonEntity:
          Name:
            NameFull: Mukhopadhyay P
      – PersonEntity:
          Name:
            NameFull: Saenz-Ponce N
      – PersonEntity:
          Name:
            NameFull: Dantzic DD
      – PersonEntity:
          Name:
            NameFull: Simpson F
      – PersonEntity:
          Name:
            NameFull: Saunders NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2015 Aug
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1